Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study

ConclusionBoth dual and triple therapy regimes resulted in SVR rates of >95% in CHC genotype 3 who were naive non-cirrhotics. However, the SVR rates were low in treatment-experienced cirrhotics.

http://link.springer.com/10.1007/s12072-017-9794-1

Source: Hepatology International - March 31, 2017 Category: Infectious Diseases Source Type: research